CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dugel Pravin −$233K Reporting owner sold <1% of stake
- Saroj Namrata −$232K Chief Business Officer sold 14% of stake
- Heier Jeffrey S. −$112K Chief Scientific Officer sold 4% of stake
- Kaiser Peter −$103K Chief Development Officer sold 5% of stake
- Anderman Todd −$87K Chief Legal Officer sold 8% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-06-02 | PEACOCK BRUCE Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2016-06-02 | Heier Jeffrey S. Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2016-06-02 | OSHEA WILLIAM J Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2016-06-02 | LINDSTROM RICHARD L MD Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2016-02-02 | Smith W Bradford | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2016-02-02 | Ankerud Eric | Grant or award · Stock Option (Right to Buy) | +57,500 | 57,500 | ||
| 2016-02-02 | Fortune James Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2016-02-02 | Sawhney Amarpreet President and CEO | Grant or award · Stock Option (Right to Buy) | +235,000 | 235,000 | ||
| 2015-11-17 | Sawhney Amarpreet President and CEO | Purchase | +10,000 | $8.25 | $83K | 563,733 |
| 2015-11-05 | OSHEA WILLIAM J Director | Grant or award · Stock Option (Right to Buy) | +11,363 | 11,363 | ||
| 2015-09-15 | Fortune James Chief Operating Officer | Sale | −9,470 | $17.16 | $163K | 112,060 |
| 2015-09-14 | Sawhney Amarpreet President and CEO | Purchase | +11,328 | $16.36 | $185K | 550,061 |
| 2015-09-14 | Sawhney Amarpreet President and CEO | Purchase | +3,672 | $16.92 | $62K | 553,733 |
| 2015-09-11 | Heier Jeffrey S. Director | Grant or award · Stock Option (Right to Buy) | +11,363 | 11,363 | ||
| 2015-06-15 | Versant Venture Capital III, L.P. 10% owner | Sale | −318,122 | $22.00 | $7.0M | 2,202,377 |
| 2015-06-15 | Versant Venture Capital III, L.P. 10% owner | Sale | −1,878 | $22.00 | $41K | 13,007 |
| 2015-06-15 | Warden Charles M Director | Sale | −318,122 | $22.00 | $7.0M | 2,202,377 |
| 2015-06-15 | Warden Charles M Director | Sale | −1,878 | $22.00 | $41K | 13,007 |
| 2015-06-11 | PEACOCK BRUCE Director | Grant or award · Stock Option (Right to Buy) | +5,681 | 5,681 | ||
| 2015-06-11 | Chadha Jaswinder Director | Grant or award · Stock Option (Right to Buy) | +5,681 | 5,681 |
Page 21 of 27 · 522 trades